Neither one is better across the board. It depends entirely on the situation. Gallstones causing pain, infection or complications need the gallbladder out. Silent stones found by chance, with no symptoms and no risk factors, are usually just watched. The deciding factors are symptoms, stone size, and whether there’s any raised cancer risk in the picture.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “The question isn’t which is better, it’s which is right for this patient. A symptomatic gallbladder needs to come out, no debate. But operating on silent stones that may never cause trouble is overtreatment. Where I pay real attention is the cancer angle, large stones or a calcified gallbladder change the maths entirely. That’s when removal earns its place even without symptoms.”

Surgery becomes the clear choice once stones start causing trouble or raise the risk of something worse.

• Symptoms : Pain, nausea, attacks after fatty meals. Once stones are symptomatic, they tend to keep causing trouble, so removal makes sense.
• Complications : Infection, a blocked duct, pancreatitis. These are reasons to operate without delay, since they can turn serious fast.
• Cancer risk : Stones over 3 cm or a calcified porcelain gallbladder raise cancer risk. That tips the decision toward removal even when silent.
• The fix is clean : Laparoscopic removal is a well established, low risk operation. The gallbladder isn’t essential, so life continues normally without it.

For symptomatic or high risk cases, the right gallbladder cancer prevention often means not waiting around for trouble to develop.

Here’s how the two approaches line up side by side.

• Silent stones : Most gallstones never cause a single symptom. For those, surgery would be treating a problem that may never actually arrive.
• The watch approach : Observation means monitoring and acting only if symptoms or risk appear. Sensible, as long as nothing changes.
• When watching fails : If a watched gallbladder starts causing attacks, surgery moves back on the table. The plan isn’t fixed forever.
• Risk tips it : The moment cancer risk factors show up, observation stops being the safe option. That’s the line that changes everything.

This decision follows the same logic as when surgery is needed for any condition, weighing the benefit of acting against the cost of waiting.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. His perspective on gallbladder disease is shaped by treating gallbladder cancer, so he reads the risk factors others might overlook, large stones, a calcified wall, a thickened gallbladder. The approach is to operate when it genuinely helps and to watch when surgery would add nothing. That judgement is what separates good care from reflex surgery.

The cancer lens is what makes the difference here. A general view might watch a silent gallbladder indefinitely, but certain features quietly raise the risk of malignancy, and those deserve action. Knowing which gallbladders to remove and which to leave alone, especially where cancer risk is involved, is exactly the kind of call experience sharpens. Right surgery, right patient, right time.

References

1. Watchful waiting versus surgery for gallstones — National Library of Medicine
2. Gallstone size and gallbladder cancer risk — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Age by itself doesn’t rule out cancer surgery. A fit 80 year old often handles surgery better than an unwell 60 year old. What actually matters is overall health, heart and lung function, other illnesses, and the stage of the cancer. Doctors weigh the whole person, not the number on a birth certificate. Many older patients come through major surgery very well.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “I’ve operated on patients in their 80s who recovered faster than people half their age. Age is just one part of the picture. What I’m really assessing is fitness, the heart, the lungs, how well they’ll tolerate the operation. Writing someone off because of a number means denying them a treatment that could cure them. The assessment is what matters, not the age.”

The decision rests on a careful look at the whole patient, not their age.

• Overall fitness : How active and independent someone is tells you more than their age. A fit older patient is a strong candidate.
• Heart and lungs : These get checked closely, since they bear the stress of anaesthesia and surgery. Good function opens the door.
• Other illnesses : Diabetes, kidney issues, heart disease all factor in. They don’t automatically rule out surgery, but they’re managed first.
• The cancer itself : Stage and type matter too. An operable tumour in a reasonably fit patient is worth treating, whatever the age.

This is why a proper assessment comes first, and minimally invasive surgery often makes the difference for an older patient who’d struggle with open surgery.

Several things make surgery safer for older patients than it used to be.

• Geriatric assessment : A structured check of fitness, memory and frailty flags problems early and shapes a plan around the individual.
• Prehabilitation : Building strength and nutrition in the weeks before surgery helps an older body withstand the operation better.
• Minimally invasive : Smaller incisions mean less blood loss, less pain and a faster recovery. For an older patient, that’s a huge advantage.
• Optimising first : Existing conditions get tuned up before surgery. A well controlled heart or sugar level changes the whole risk picture.

The single biggest help is the gentler approach, and laparoscopic cancer surgery gives older patients a recovery that open surgery often can’t match.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He operates on patients across the age range, including the elderly, where careful assessment and minimally invasive technique decide everything. The approach starts with judging fitness honestly rather than ruling someone out by age, since an older patient often has far more to gain from surgery than people assume.

For elderly patients, the surgical approach is the whole game. A minimally invasive operation with small incisions, little blood loss and early mobility is something an older body handles far better than a long open procedure. Matched to a patient who’s been properly assessed and prepared, surgery at an advanced age isn’t reckless. It’s often the best chance they have.

References

1. Laparoscopic colorectal surgery outcomes in elderly over 80 — National Library of Medicine
2. Gastric cancer surgery outcomes in elderly patients — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Pancreatic cancer is mostly a disease of older age, but young adults can get it too. Cases under 50, called early-onset pancreatic cancer, are uncommon, making up a small slice of the total. Still, the numbers are rising. When it does strike young, it’s more often tied to inherited genes than to age or lifestyle alone.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “Pancreatic cancer in a young person is rare, but I’ve seen it, and it tends to catch everyone off guard. Nobody suspects it at 35, so the diagnosis often comes late. When it does appear young, genetics usually has a hand in it. That’s why family history matters so much here. A young patient with the right red flags deserves a proper look, not reassurance.”

When pancreatic cancer turns up young, certain factors are usually in play.

• Inherited genes : Faults like BRCA2, PALB2 and others run through families and can trigger pancreatic cancer decades earlier than usual.
• Family history : Several affected relatives is one of the strongest signals. The more relatives, the higher the risk in younger members.
• Smoking : Starting young and smoking heavily is an independent risk factor. It’s one of the few causes that’s actually within reach.
• Chronic pancreatitis : Long term inflammation of the pancreas, sometimes from hereditary causes, raises the risk over years.

Knowing the risk pattern matters, and proper pancreatic cancer care for young patients starts with taking their history seriously.

In young people, this cancer hides behind low suspicion and vague symptoms.

• Nobody suspects it : A 30 something with stomach pain gets investigated for almost anything before pancreatic cancer. The age throws doctors off.
• Vague symptoms : Back pain, indigestion, mild weight loss. Easy to brush aside, and they overlap with dozens of harmless conditions.
• No screening : There’s no routine pancreatic cancer screening for the general population, so nothing catches it before symptoms appear.
• New diabetes clue : Sudden diabetes in a slim young adult is an underused warning sign. Sometimes the pancreas is signalling something.

The delay is what makes age matter, and pancreatic cancer survival shifts sharply depending on how early the disease is found.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He treats pancreatic cancer across all ages, including robotic Whipple surgery, and pays close attention to younger patients where family history and genetics shape the picture. The approach starts with not dismissing symptoms because of someone’s age, since that assumption is exactly what delays these diagnoses. Taking a young patient seriously is what catches it in time.

Age changes the stakes here. A young patient often has a stronger body to withstand major surgery, but only if the cancer is caught while it’s still operable. That window is everything with pancreatic cancer. Recognising the inherited patterns, acting on the red flags, and not waiting for certainty is what gives a young patient their best chance at a real outcome.

References

1. Trends in early-onset pancreatic cancer — National Library of Medicine
2. Characteristics of early-onset pancreatic cancer — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Cancer rehabilitation helps patients rebuild strength, function and daily life during and after treatment. Cancer and its treatment take a real toll, on the body, on energy, on the ability to do ordinary things. Rehab is the structured work of getting those back. It isn’t an afterthought to treatment. It’s part of recovering properly from it.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “We focus so hard on removing the cancer that recovery sometimes gets treated as something that just happens on its own. It doesn’t. Surgery, chemo and radiation leave patients weak, fatigued, sometimes with lasting effects. Rehabilitation is how we help them get back to their lives, not just survive the treatment. It’s a real part of the plan, not a bonus.”

It’s a coordinated effort across several areas, matched to what each patient actually needs.

• Physiotherapy : Targeted exercises rebuild strength and mobility lost to surgery or long treatment. Often the backbone of the whole programme.
• Managing fatigue : Cancer fatigue is brutal and doesn’t lift with rest alone. Structured activity, oddly enough, is what helps most.
• Nutrition : Treatment wrecks appetite and weight. A dietitian helps rebuild the nourishment the body needs to actually repair itself.
• Emotional support : The mental load is real. Counselling and psychological support are as much a part of rehab as any physical exercise.

Rehab is lighter when the surgery itself was gentler, and minimally invasive robotic cancer surgery means less to recover from in the first place.

Rehabilitation shapes not just whether someone recovers, but how well they live afterward.

• Faster return : Structured rehab gets people back to work, family and normal life sooner than leaving recovery to chance.
• Fewer lasting effects : Issues like lymphoedema, stiffness or weakness are far easier to manage when rehab catches them early.
• Tolerating treatment : A stronger, better nourished patient handles chemotherapy and further treatment better. Rehab feeds back into the cancer care itself.
• Quality of life : Beyond survival, rehab is about living well after cancer. That distinction matters enormously to patients.

This is the same principle behind faster recovery after surgery, where active, structured recovery beats simply waiting to heal.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. His approach treats recovery as part of cancer care, not an afterthought, so patients are supported through rehabilitation alongside their surgical treatment. Minimally invasive surgery is the foundation, since less surgical trauma means a far easier path back to strength. That whole-journey view is what sets good cancer care apart.

Recovery is where the quality of the surgery shows itself. A patient who had a small incision, walked the next day and avoided complications has a far shorter road through rehab than one who didn’t. Building the recovery in from the start, through gentler surgery and structured support, is what gets people back to their lives. Surviving cancer is the goal. Living well afterward is the point.

References

1. Cancer rehabilitation expert recommendations — National Library of Medicine
2. Oncologic rehabilitation and quality of life — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

A biopsy confirms cancer and its type. Molecular testing goes a step further, reading the tumour’s genes and proteins to understand what’s actually driving it. That detail matters because two cancers that look identical under a microscope can behave completely differently, and respond to completely different drugs. The test is what reveals which one you’re dealing with.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “The biopsy tells us it’s cancer and what kind. Molecular testing tells us how it ticks. We’re looking for specific mutations, the ones a targeted drug can switch off. Without that information you’re treating blind. With it, you can sometimes skip the heavy chemotherapy entirely and hit the exact fault driving the tumour. That’s the whole shift in modern oncology.”

It digs into the tumour’s biology, looking for the specific faults that drive it.

• Driver mutations : Certain genes, when faulty, push a cancer to grow. Testing finds them, and many now have a drug built to target them.
• Receptors : Breast and other cancers are checked for hormone receptors and HER2. Those results decide whole categories of treatment.
• Immunotherapy markers : Some tumours carry signals, like PD-L1, that predict whether immunotherapy will work. Testing flags them upfront.
• Resistance clues : The profile can hint at which drugs a tumour will shrug off, saving the patient from a treatment that won’t work.

This is the information that decides whether robotic cancer surgery alone is enough or whether targeted drugs need to join the plan.

The results don’t just describe the cancer. They actively redirect how it’s treated.

• Targeted therapy : Find a driver mutation with a matching drug, and treatment can hit that exact fault. Far more precise than blanket chemotherapy.
• Sparing chemo : Sometimes the profile shows a targeted drug will outperform chemotherapy. The patient avoids the harsher option altogether.
• Sequencing the plan : The results help decide what comes first, surgery, drugs, or a combination. Order matters, and this informs it.
• A clearer prognosis : The molecular picture often refines the outlook, giving patient and doctor a more honest sense of what lies ahead.

All of this builds on what your biopsy report first reveals, taking that same tissue sample and extracting far more from it.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. His diagnostic approach treats molecular testing as a core step, not an afterthought, so treatment is built on the tumour’s actual biology rather than its appearance alone. Every result goes through tumour board review, where surgeons and oncologists read the molecular picture together. That integration is what turns a test result into the right plan.

Molecular detail is where modern cancer care separates itself from the old one size fits all approach. The same diagnosis can need very different treatment depending on what the genes show. Reading that correctly, and acting on it, is what lets a patient get the precise therapy their cancer responds to. Used well, it means better outcomes with less unnecessary treatment.

References

1. Molecular profiling of advanced malignancies — National Library of Medicine
2. Molecular genetic testing and targeted therapy — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Air pollution is a proven cause of lung cancer, and India’s pollution levels make that a real concern. It isn’t only a smoker’s disease anymore. The tiny particles in polluted air, especially PM2.5, get deep into the lungs and damage cells over years. In cities where the air stays toxic for months, that exposure adds up to a genuine cancer risk.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “We’re seeing lung cancer in people who never touched a cigarette, and pollution is a big part of why. The fine particles in dirty air carry carcinogens straight into the lungs. Breathe that in day after day for years and the risk is real. In our most polluted cities, the air itself has become a risk factor we can’t ignore.”

The damage comes from what’s actually floating in the air and how deep it travels.

• PM2.5 particles : These are small enough to reach the deepest parts of the lung. Once there, they lodge and irritate tissue for years.
• Carcinogens onboard : Polluted air carries known cancer causing chemicals, from vehicle exhaust to industrial output. The particles ferry them right in.
• Chronic inflammation : Constant exposure keeps the lungs inflamed. That ongoing irritation is the kind of slow damage that lets cancer take hold.
• Years of exposure : It’s not one bad day. It’s breathing polluted air daily over years that builds the risk, quietly and steadily.

This is why pollution sits alongside other causes, and proper lung cancer treatment increasingly sees patients with no smoking history at all.

Pollution related lung cancer doesn’t hit everyone equally. Some are far more exposed.

• City dwellers : People in high pollution cities breathe far more PM2.5 than rural populations. The long term exposure is simply higher.
• Non smokers too : You don’t have to smoke to be at risk. A rising share of lung cancers now appear in lifelong non smokers.
• Indoor smoke : Biomass cooking fuels and indoor smoke add their own load, hitting women in many Indian households particularly hard.
• Outdoor workers : Traffic police, street vendors, construction workers. Anyone spending long hours in polluted air carries a heavier exposure.

Pollution and tobacco often work together, which is why understanding smoking and lung cancer completes the picture of what’s driving the disease in India.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He treats lung cancer across the spectrum, including the growing group of non smoking patients whose disease is driven by pollution and other factors. The approach starts with not assuming, since a non smoker with a lung mass deserves the same careful workup as anyone else. That openness is what catches these cancers in people who’d never expect them.

The shift matters clinically. Lung cancer in non smokers often behaves differently and carries different mutations, which changes how it’s treated. Recognising that a patient’s cancer may be pollution linked rather than smoking linked shapes the whole plan. Minimally invasive surgery like VATS, in experienced hands, then offers these patients a recovery that fits the early stage many of them are caught at.

References

1. Air pollution and lung cancer in never smokers — National Library of Medicine
2. Risk factors for lung cancer among never smokers — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.